Biotech China 2014

Oncology: Roche AG

Total Score People Score Events Score
23 17 17
Date Event Presentation Speakers
May 28, 2013 NGS Translate Panel: To Outsource or not to Outsource? Working Effectively with Technology Providers James Cai
March 26, 2012 World Companion Diagnostics Summit Europe Roche Personalised Healthcare: Identifying Key Factors for the Success of a Personalised Medicine Approach Gerd Maass
Personalised Healthcare in Oncology Drug Discovery & Development at Roche Martin Steegmaier
March 14, 2012 Imaging in Cancer Drug Development New Presentation Werner Scheuer,
Chairman's Opening Remarks Werner Scheuer,
March 7, 2011 Imaging in Cancer Drug Development Application of different imaging modalities in the drug development process Werner Scheuer,
June 10, 2009 Inaugural Risk Management and Drug Safety Strategies for Better Decision Making How Can We Ensure Patient Safety? David Brewster
January 28, 2009 Clinical Trials for Special Populations Biomarkers in oncology clinical trials Chee Gee See
Successful alternatives: A case study contrasting two different, but successful, strategies generating sufficient data from an elderly population to permit licensure of novel antiviral treatments for influenza Penelope Ward
January 26, 2009 Biomarker Assay Development Biomarker and Companion Diagnostics Assay Development: An IVD Perspective Thomas Li
January 5, 2009 High Content Analysis Advanced Workshop Part II: Assay Development Ann F Hoffman
Data Management in the HCAWorld Keith Grochow
November 17, 2008 BIO-Europe 2008 Early Stage Dealmaking – How to Build Value Instead of Giving it Away Sarah Holland
May 4, 2008 Impact China IV: Pharmaceutical R&D Global Summit Elective: Track A: Collaborations & Partnerships: Effective Partnerships: Working with Academic Centers in China Yun He
March 25, 2008 Molecular Diagnostics Chairperson’s Remarks Linda McAllister
Personalized Health Care at Roche: Development of Tests for Response Prediction in Oncology Gerd Maass
Organizational, Strategic and Technical Considerations for Creating Clinically Differentiated Medicines and Companion Diagnostics: Successes vs. Failures, What Did We Learn? Tim M. Jaeger
March 25, 2008 R&D Risk Mitigation Chairperson’s Remarks Linda McAllister
Personalized Health Care at Roche: Development of Tests for Response Prediction in Oncology Gerd Maass
March 25, 2008 Preclinical Development From Publication to Practice: Interlaboratory Validation of Microarray and QPCR-based Signatures for Predicting Carcinogenicity in the Rat Mark Fielden
March 25, 2008 CANCER MOLECULAR MARKERS Personalized Health Care at Roche: Development of Tests for Response Prediction in Oncology Gerd Maass
March 25, 2008 TRENDS IN DRUG SAFETY From Publication to Practice: Interlaboratory Validation of Mark Fielden
March 16, 2008 Advances in Cancer Research: From the Laboratory to the Clinic SESSION D: SCIENTIFIC WRITING AND THE PUBLICATION PROCESS Tom Curran
Dealing with the Necessary Evils: Editors and Reviewers Tom Curran
Targeting the Hedgehog Pathway in Pediatric Brain Tumors Tom Curran
November 5, 2007 Second Annual Biomarkers Europe Nov (05-06) BIOMARKERS IN PERSONALIZED MEDICINE (13:10-17:00) Stefan Scherer
BIOMARKERS IN PERSONALIZED MEDICINE: Personalized Healthcare and Biomarker Strategies for Cancer Therapeutics (13:45-14:15) Stefan Scherer
4th Annual Pharma R&D Asia Congress
About Us | Privacy Policy | Site Map | FAQs | Advertise With Us | Community
BiotechScienceNews.com promotes research and ranks life scientists working in the life science spectrum involving biotechnology,
drug discovery, genomics, microbiology, neuroscience, medicine, pharmacology, cell biology, and molecular biology.